Pharmacokinetics of Sufentanil Sublingual Microtablet 30 mcg and 15 mcg in Healthy Subjects

NCT02082236 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Treatment Arm A: Sufenta®
DRUG: Treatment B: Sufentanil SSM 30 mcg
DRUG: Treatment C: SSM 15 mcg
DRUG: Treatment D: SSM 30 mcg

Sponsor

Talphera, Inc